nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydroxychloroquine—Reaction gastrointestinal—Metformin—polycystic ovary syndrome	0.0245	0.159	CcSEcCtD
Hydroxychloroquine—TLR7—uterus—polycystic ovary syndrome	0.0227	0.236	CbGeAlD
Hydroxychloroquine—TLR7—adrenal gland—polycystic ovary syndrome	0.0199	0.207	CbGeAlD
Hydroxychloroquine—TLR7—vagina—polycystic ovary syndrome	0.0185	0.192	CbGeAlD
Hydroxychloroquine—TLR7—endocrine gland—polycystic ovary syndrome	0.0173	0.179	CbGeAlD
Hydroxychloroquine—Appetite absent—Metformin—polycystic ovary syndrome	0.0164	0.106	CcSEcCtD
Hydroxychloroquine—CYP2D6—urine—polycystic ovary syndrome	0.0134	0.139	CbGeAlD
Hydroxychloroquine—Primaquine—CYP1A1—polycystic ovary syndrome	0.0107	0.406	CrCbGaD
Hydroxychloroquine—Blood disorder—Metformin—polycystic ovary syndrome	0.00979	0.0634	CcSEcCtD
Hydroxychloroquine—Contusion—Metformin—polycystic ovary syndrome	0.00937	0.0607	CcSEcCtD
Hydroxychloroquine—Amodiaquine—CYP1A1—polycystic ovary syndrome	0.00914	0.345	CrCbGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—GAB1—polycystic ovary syndrome	0.00911	0.0126	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—GAB1—polycystic ovary syndrome	0.00887	0.0123	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—GAB1—polycystic ovary syndrome	0.00887	0.0123	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—ATF1—polycystic ovary syndrome	0.00881	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—INSR—polycystic ovary syndrome	0.00879	0.0122	CbGpPWpGaD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—polycystic ovary syndrome	0.00858	0.0119	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—INSR—polycystic ovary syndrome	0.00848	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—TAB1—polycystic ovary syndrome	0.00843	0.0117	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—TAB1—polycystic ovary syndrome	0.00813	0.0113	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—FGF18—polycystic ovary syndrome	0.00807	0.0112	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—TAB1—polycystic ovary syndrome	0.00749	0.0104	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—GAB1—polycystic ovary syndrome	0.00737	0.0102	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—ATF1—polycystic ovary syndrome	0.00735	0.0102	CbGpPWpGaD
Hydroxychloroquine—Lightheadedness—Metformin—polycystic ovary syndrome	0.00731	0.0474	CcSEcCtD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—ATF1—polycystic ovary syndrome	0.00722	0.00999	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—INSR—polycystic ovary syndrome	0.00705	0.00975	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—ATF1—polycystic ovary syndrome	0.00697	0.00964	CbGpPWpGaD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—TAB1—polycystic ovary syndrome	0.00678	0.00939	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—TAB1—polycystic ovary syndrome	0.00666	0.00922	CbGpPWpGaD
Hydroxychloroquine—Chloroquine—CYP1A1—polycystic ovary syndrome	0.00661	0.249	CrCbGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—TAB1—polycystic ovary syndrome	0.00643	0.00889	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—ATF1—polycystic ovary syndrome	0.00626	0.00866	CbGpPWpGaD
Hydroxychloroquine—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00608	0.0394	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—TAB1—polycystic ovary syndrome	0.00592	0.00819	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—TAB1—polycystic ovary syndrome	0.00585	0.00809	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—TAB1—polycystic ovary syndrome	0.00578	0.008	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—IRS2—polycystic ovary syndrome	0.00572	0.00791	CbGpPWpGaD
Hydroxychloroquine—Liver function test abnormal—Metformin—polycystic ovary syndrome	0.00548	0.0355	CcSEcCtD
Hydroxychloroquine—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.00542	0.0351	CcSEcCtD
Hydroxychloroquine—TLR9—PI3K Cascade—IRS1—polycystic ovary syndrome	0.00499	0.0069	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—ATF1—polycystic ovary syndrome	0.00495	0.00685	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IRS2—polycystic ovary syndrome	0.00478	0.00662	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—SULT2A1—polycystic ovary syndrome	0.00472	0.00654	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IRS2—polycystic ovary syndrome	0.00465	0.00643	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—TAB1—polycystic ovary syndrome	0.00462	0.00639	CbGpPWpGaD
Hydroxychloroquine—TLR9—PI3K Cascade—AKT2—polycystic ovary syndrome	0.00462	0.00639	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IRS2—polycystic ovary syndrome	0.00461	0.00638	CbGpPWpGaD
Hydroxychloroquine—Drowsiness—Metformin—polycystic ovary syndrome	0.00457	0.0296	CcSEcCtD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—TAB1—polycystic ovary syndrome	0.00457	0.00632	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IRS2—polycystic ovary syndrome	0.00449	0.00621	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IRS2—polycystic ovary syndrome	0.00449	0.00621	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.00422	0.00584	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IRS1—polycystic ovary syndrome	0.00417	0.00578	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IRS1—polycystic ovary syndrome	0.00406	0.00562	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IRS1—polycystic ovary syndrome	0.00402	0.00557	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IRS1—polycystic ovary syndrome	0.00392	0.00542	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IRS1—polycystic ovary syndrome	0.00392	0.00542	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—INS—polycystic ovary syndrome	0.00389	0.00538	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—AKT2—polycystic ovary syndrome	0.00386	0.00535	CbGpPWpGaD
Hydroxychloroquine—Eye disorder—Metformin—polycystic ovary syndrome	0.00384	0.0248	CcSEcCtD
Hydroxychloroquine—TLR9—IRS-related events—AKT2—polycystic ovary syndrome	0.00376	0.0052	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—INS—polycystic ovary syndrome	0.00375	0.00519	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IRS2—polycystic ovary syndrome	0.00373	0.00516	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IGF1—polycystic ovary syndrome	0.00373	0.00516	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—AKT2—polycystic ovary syndrome	0.00372	0.00515	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IGF1—polycystic ovary syndrome	0.00363	0.00502	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—AKT2—polycystic ovary syndrome	0.00363	0.00502	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—AKT2—polycystic ovary syndrome	0.00363	0.00502	CbGpPWpGaD
Hydroxychloroquine—Malnutrition—Metformin—polycystic ovary syndrome	0.00357	0.0231	CcSEcCtD
Hydroxychloroquine—Vision blurred—Metformin—polycystic ovary syndrome	0.00337	0.0218	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—UBE2H—polycystic ovary syndrome	0.00335	0.00463	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FBXO44—polycystic ovary syndrome	0.00335	0.00463	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—AKT2—polycystic ovary syndrome	0.00334	0.00462	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.0033	0.00456	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IRS1—polycystic ovary syndrome	0.00326	0.0045	CbGpPWpGaD
Hydroxychloroquine—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00314	0.0203	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—INS—polycystic ovary syndrome	0.00312	0.00431	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Fatty Acid Omega Oxidation—CYP1A1—polycystic ovary syndrome	0.00309	0.00427	CbGpPWpGaD
Hydroxychloroquine—Unspecified disorder of skin and subcutaneous tissue—Metformin—polycystic ovary syndrome	0.00302	0.0196	CcSEcCtD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—AKT2—polycystic ovary syndrome	0.00301	0.00417	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ARHGAP30—polycystic ovary syndrome	0.00298	0.00412	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ARHGAP23—polycystic ovary syndrome	0.00298	0.00412	CbGpPWpGaD
Hydroxychloroquine—Oedema—Metformin—polycystic ovary syndrome	0.00292	0.0189	CcSEcCtD
Hydroxychloroquine—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00286	0.0185	CcSEcCtD
Hydroxychloroquine—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00285	0.0185	CcSEcCtD
Hydroxychloroquine—Skin disorder—Metformin—polycystic ovary syndrome	0.00283	0.0183	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—FGF18—polycystic ovary syndrome	0.00283	0.00391	CbGpPWpGaD
Hydroxychloroquine—Anorexia—Metformin—polycystic ovary syndrome	0.00278	0.018	CcSEcCtD
Hydroxychloroquine—TLR7—Immune System—PTAFR—polycystic ovary syndrome	0.00276	0.00381	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FBXO44—polycystic ovary syndrome	0.00264	0.00366	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—UBE2H—polycystic ovary syndrome	0.00264	0.00366	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—AKT2—polycystic ovary syndrome	0.00261	0.00361	CbGpPWpGaD
Hydroxychloroquine—Somnolence—Metformin—polycystic ovary syndrome	0.00259	0.0168	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—GAB1—polycystic ovary syndrome	0.00258	0.00357	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Xenobiotics—CYP1A1—polycystic ovary syndrome	0.00258	0.00357	CbGpPWpGaD
Hydroxychloroquine—Decreased appetite—Metformin—polycystic ovary syndrome	0.00253	0.0164	CcSEcCtD
Hydroxychloroquine—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.00252	0.0163	CcSEcCtD
Hydroxychloroquine—Fatigue—Metformin—polycystic ovary syndrome	0.00251	0.0163	CcSEcCtD
Hydroxychloroquine—CYP2D6—Tamoxifen metabolism—CYP1A1—polycystic ovary syndrome	0.00248	0.00343	CbGpPWpGaD
Hydroxychloroquine—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.00238	0.0154	CcSEcCtD
Hydroxychloroquine—CYP2D6—female gonad—polycystic ovary syndrome	0.00238	0.0247	CbGeAlD
Hydroxychloroquine—Urticaria—Metformin—polycystic ovary syndrome	0.00232	0.015	CcSEcCtD
Hydroxychloroquine—TLR7—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.00231	0.0032	CbGpPWpGaD
Hydroxychloroquine—Abdominal pain—Metformin—polycystic ovary syndrome	0.00231	0.0149	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—FGF18—polycystic ovary syndrome	0.00224	0.00309	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00221	0.023	CbGeAlD
Hydroxychloroquine—TLR7—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—polycystic ovary syndrome	0.00219	0.00303	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PTAFR—polycystic ovary syndrome	0.00218	0.00301	CbGpPWpGaD
Hydroxychloroquine—TLR7—MyD88 dependent cascade initiated on endosome—IL6—polycystic ovary syndrome	0.00215	0.00297	CbGpPWpGaD
Hydroxychloroquine—Asthenia—Metformin—polycystic ovary syndrome	0.00209	0.0135	CcSEcCtD
Hydroxychloroquine—TLR7—Toll Like Receptor 9 (TLR9) Cascade—IL6—polycystic ovary syndrome	0.00207	0.00287	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FLT4—polycystic ovary syndrome	0.00206	0.00286	CbGpPWpGaD
Hydroxychloroquine—Pruritus—Metformin—polycystic ovary syndrome	0.00206	0.0134	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—GAB1—polycystic ovary syndrome	0.00204	0.00283	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—ATF1—polycystic ovary syndrome	0.00203	0.00281	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—RACGAP1—polycystic ovary syndrome	0.00203	0.0028	CbGpPWpGaD
Hydroxychloroquine—Diarrhoea—Metformin—polycystic ovary syndrome	0.002	0.0129	CcSEcCtD
Hydroxychloroquine—Dizziness—Metformin—polycystic ovary syndrome	0.00193	0.0125	CcSEcCtD
Hydroxychloroquine—CYP2D6—Melatonin metabolism and effects—CYP1A1—polycystic ovary syndrome	0.00192	0.00265	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.00191	0.00264	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—TAB1—polycystic ovary syndrome	0.00187	0.00259	CbGpPWpGaD
Hydroxychloroquine—Vomiting—Metformin—polycystic ovary syndrome	0.00185	0.012	CcSEcCtD
Hydroxychloroquine—Rash—Metformin—polycystic ovary syndrome	0.00184	0.0119	CcSEcCtD
Hydroxychloroquine—Dermatitis—Metformin—polycystic ovary syndrome	0.00184	0.0119	CcSEcCtD
Hydroxychloroquine—Headache—Metformin—polycystic ovary syndrome	0.00183	0.0118	CcSEcCtD
Hydroxychloroquine—TLR9—Innate Immune System—TNRC6B—polycystic ovary syndrome	0.00183	0.00253	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP11A1—polycystic ovary syndrome	0.00181	0.0025	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NPB—polycystic ovary syndrome	0.0018	0.0025	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP11A1—polycystic ovary syndrome	0.00178	0.00247	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-mediated signalling—IL6—polycystic ovary syndrome	0.00175	0.00242	CbGpPWpGaD
Hydroxychloroquine—Nausea—Metformin—polycystic ovary syndrome	0.00173	0.0112	CcSEcCtD
Hydroxychloroquine—TLR9—TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation—IL6—polycystic ovary syndrome	0.00173	0.00239	CbGpPWpGaD
Hydroxychloroquine—TLR9—MyD88 dependent cascade initiated on endosome—IL6—polycystic ovary syndrome	0.0017	0.00235	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events—IL6—polycystic ovary syndrome	0.0017	0.00235	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1C2—polycystic ovary syndrome	0.00169	0.00234	CbGpPWpGaD
Hydroxychloroquine—TLR9—IRS-related events triggered by IGF1R—IL6—polycystic ovary syndrome	0.00168	0.00233	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP17A1—polycystic ovary syndrome	0.00168	0.00232	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP17A1—polycystic ovary syndrome	0.00166	0.00229	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—FGF18—polycystic ovary syndrome	0.00165	0.00228	CbGpPWpGaD
Hydroxychloroquine—TLR9—IGF1R signaling cascade—IL6—polycystic ovary syndrome	0.00164	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Insulin receptor signalling cascade—IL6—polycystic ovary syndrome	0.00164	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll Like Receptor 9 (TLR9) Cascade—IL6—polycystic ovary syndrome	0.00164	0.00227	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.00163	0.00226	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—ATF1—polycystic ovary syndrome	0.0016	0.00222	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—RACGAP1—polycystic ovary syndrome	0.0016	0.00222	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—NRG1—polycystic ovary syndrome	0.00153	0.00211	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-like Receptor Signaling Pathway—IL6—polycystic ovary syndrome	0.00151	0.00209	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00151	0.00208	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00151	0.00208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—GAB1—polycystic ovary syndrome	0.0015	0.00208	CbGpPWpGaD
Hydroxychloroquine—TLR7—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.00149	0.00206	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—TAB1—polycystic ovary syndrome	0.00148	0.00205	CbGpPWpGaD
Hydroxychloroquine—TLR7—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.00147	0.00204	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP11A1—polycystic ovary syndrome	0.00146	0.00203	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.00141	0.00195	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00137	0.00189	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CAMK2D—polycystic ovary syndrome	0.00137	0.00189	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling by Insulin receptor—IL6—polycystic ovary syndrome	0.00136	0.00188	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP17A1—polycystic ovary syndrome	0.00136	0.00188	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TNRC6B—polycystic ovary syndrome	0.00135	0.00186	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.00133	0.00184	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP19A1—polycystic ovary syndrome	0.00133	0.00184	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP19A1—polycystic ovary syndrome	0.00131	0.00182	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—CRP—polycystic ovary syndrome	0.00131	0.00181	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IRS2—polycystic ovary syndrome	0.00131	0.00181	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—FGF18—polycystic ovary syndrome	0.0013	0.0018	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—INHBB—polycystic ovary syndrome	0.0013	0.00179	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.00121	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—NRG1—polycystic ovary syndrome	0.00121	0.00167	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—GAB1—polycystic ovary syndrome	0.00119	0.00165	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—ATF1—polycystic ovary syndrome	0.00118	0.00163	CbGpPWpGaD
Hydroxychloroquine—TLR9—Regulation of toll-like receptor signaling pathway—IL6—polycystic ovary syndrome	0.00118	0.00163	CbGpPWpGaD
Hydroxychloroquine—TLR9—Toll-Like Receptors Cascades—IL6—polycystic ovary syndrome	0.00117	0.00161	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IRS1—polycystic ovary syndrome	0.00114	0.00158	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FSHR—polycystic ovary syndrome	0.0011	0.00152	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—TAB1—polycystic ovary syndrome	0.00109	0.00151	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—PRL—polycystic ovary syndrome	0.00108	0.00149	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CAMK2D—polycystic ovary syndrome	0.00108	0.00149	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP19A1—polycystic ovary syndrome	0.00108	0.00149	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.00107	0.00148	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TNRC6B—polycystic ovary syndrome	0.00106	0.00147	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.00106	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—AKT2—polycystic ovary syndrome	0.00106	0.00146	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00104	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IRS2—polycystic ovary syndrome	0.00103	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—CRP—polycystic ovary syndrome	0.00103	0.00143	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.00101	0.00139	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FST—polycystic ovary syndrome	0.000982	0.00136	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.00097	0.00134	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LHB—polycystic ovary syndrome	0.000959	0.00133	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000941	0.0013	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000937	0.0013	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—ATF1—polycystic ovary syndrome	0.000934	0.00129	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—BCL2—polycystic ovary syndrome	0.000923	0.00128	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL18—polycystic ovary syndrome	0.000909	0.00126	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000907	0.00126	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IRS1—polycystic ovary syndrome	0.000902	0.00125	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SCT—polycystic ovary syndrome	0.000898	0.00124	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—NRG1—polycystic ovary syndrome	0.000889	0.00123	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000879	0.00122	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000869	0.0012	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000866	0.0012	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—TAB1—polycystic ovary syndrome	0.000862	0.00119	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000857	0.00119	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—PRL—polycystic ovary syndrome	0.000854	0.00118	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000842	0.00117	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000835	0.00116	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—AKT2—polycystic ovary syndrome	0.000835	0.00116	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000799	0.00111	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—YAP1—polycystic ovary syndrome	0.00078	0.00108	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000778	0.00108	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000769	0.00106	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000767	0.00106	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRS2—polycystic ovary syndrome	0.000761	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—CRP—polycystic ovary syndrome	0.000761	0.00105	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—INSR—polycystic ovary syndrome	0.000735	0.00102	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—BCL2—polycystic ovary syndrome	0.000729	0.00101	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000725	0.001	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000723	0.001	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL18—polycystic ovary syndrome	0.000718	0.000994	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000714	0.000987	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—NRG1—polycystic ovary syndrome	0.000703	0.000972	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000699	0.000966	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000688	0.000951	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PGR—polycystic ovary syndrome	0.000681	0.000942	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IRS1—polycystic ovary syndrome	0.000665	0.000919	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000648	0.000896	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000633	0.000876	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000633	0.000876	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—AKT2—polycystic ovary syndrome	0.000615	0.000851	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000604	0.000835	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—CRP—polycystic ovary syndrome	0.000602	0.000833	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRS2—polycystic ovary syndrome	0.000602	0.000833	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000589	0.000815	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000573	0.000792	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000565	0.000781	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000557	0.000771	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—PRL—polycystic ovary syndrome	0.000552	0.000764	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—BCL2—polycystic ovary syndrome	0.000537	0.000743	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IRS1—polycystic ovary syndrome	0.000525	0.000727	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000524	0.000725	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—AKT2—polycystic ovary syndrome	0.000486	0.000673	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000486	0.000672	CbGpPWpGaD
Hydroxychloroquine—TLR7—Innate Immune System—IL6—polycystic ovary syndrome	0.000477	0.000661	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000463	0.00064	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000461	0.000638	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000455	0.00063	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000454	0.000628	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—BCL2—polycystic ovary syndrome	0.000425	0.000588	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000406	0.000562	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000389	0.000538	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—LEP—polycystic ovary syndrome	0.000381	0.000527	CbGpPWpGaD
Hydroxychloroquine—TLR9—Innate Immune System—IL6—polycystic ovary syndrome	0.000377	0.000522	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000371	0.000514	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000371	0.000514	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000345	0.000478	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.000344	0.000476	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IRS1—polycystic ovary syndrome	0.00034	0.00047	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—POMC—polycystic ovary syndrome	0.000327	0.000453	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—INS—polycystic ovary syndrome	0.000325	0.00045	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000315	0.000435	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000314	0.000435	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000299	0.000413	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000293	0.000406	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000293	0.000406	CbGpPWpGaD
Hydroxychloroquine—TLR7—Immune System—IL6—polycystic ovary syndrome	0.000278	0.000385	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000246	0.00034	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000233	0.000323	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000222	0.000308	CbGpPWpGaD
Hydroxychloroquine—TLR9—Immune System—IL6—polycystic ovary syndrome	0.00022	0.000304	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000206	0.000284	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000198	0.000274	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000189	0.000262	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000172	0.000239	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000169	0.000233	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000163	0.000226	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.00015	0.000208	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000146	0.000201	CbGpPWpGaD
Hydroxychloroquine—TLR9—Signaling Pathways—IL6—polycystic ovary syndrome	0.000142	0.000197	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.00014	0.000194	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000135	0.000186	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000133	0.000184	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000126	0.000174	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000124	0.000171	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—TH—polycystic ovary syndrome	0.000107	0.000148	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	0.000104	0.000144	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	9.79e-05	0.000135	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	8.74e-05	0.000121	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	8.33e-05	0.000115	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	7.89e-05	0.000109	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	7.36e-05	0.000102	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.97e-05	8.25e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	5.88e-05	8.14e-05	CbGpPWpGaD
Hydroxychloroquine—CYP2D6—Metabolism—INS—polycystic ovary syndrome	5.85e-05	8.1e-05	CbGpPWpGaD
